questionText: To ask the Secretary of State for Health and Social Care, if she will provide a timescale of when she expects (a) NHS England to conclude its commercial negotiations with Vertex Pharmaceuticals and (b) NICE to issue final guidance on NHS availability of Kaftrio for new patients.
answerText: Commercial negotiations between NHS England and Vertex remain on track and are being undertaken constructively, and within a confidential environment, to best enable progress. NHS England remains committed to ensuring patients, and the wider community of ...
heading: Ivacaftor/tezacaftor/elexacaftor: Vertex